Roger Lyons, MD, FACP, Discusses Real-World Treatment, Survival Patterns in Patients with MDS

By Cecilia Brown, Roger Lyons, MD, FACP - Last Updated: December 11, 2022

Roger Lyons, MD, FACP, discusses a real-world retrospective observational study on treatment patterns and overall survival among patients with myelodysplastic syndromes treated in the US community oncology setting. Dr. Lyons and colleagues presented the research at the 2022 American Society of Hematology Annual Meeting.

Post Tags:MDS ASH 22
Editorial Board